National Cancer Institute®
Last Modified: October 1, 2002
1
UI - 4017364
AU - Shinotoh H; Kazahaya Y; Yamada T; Kita K; Hirayama K
TI -
[Subacute combined degeneration of spinal cord. Significance of
peripheral nerve involvement]
SO - Rinsho Shinkeigaku 1985 Mar;25(3):320-6
2
UI - 10348814
AU - Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A;
TI -
Thompson DG; Dockray GJ
Mutations of RegIalpha are associated with enterochromaffin-like cell
tumor development in patients with hypergastrinemia.
SO - Gastroenterology 1999 Jun;116(6):1310-8
AD - The Physiological Laboratory, University of Liverpool, Liverpool,
England.
BACKGROUND & AIMS: The RegIalpha gene (Reg) encodes a secretory protein
proposed to regulate islet beta-cell and gastric mucous cell growth. Reg
is expressed in rat gastric enterochromaffin-like (ECL) cells. The aim
of this study was to examine Reg expression in human corpus and to
determine the identity of Reg in ECL cell carcinoid tumors in
hypergastrinemic patients. METHODS: Reg messenger RNA (mRNA) abundance
was quantified by Northern blot in extracts of gastric corpus from
patients with and without ECL cell tumors and in AR4-2J cells stimulated
by gastrin; cellular origins were determined by immunocytochemistry.
Mutations of Reg were determined by reverse-transcription polymerase
chain reaction, cloning, and sequencing, and the mutated protein was
expressed in HIT-T15 cells. RESULTS: Reg mRNA abundance was increased
approximately threefold in the corpus of hypergastrinemic patients
compared with controls, and was enriched in 3 of 7 ECL cell carcinoid
tumors but not in non-endocrine cell gastric polyps. In AR4-2J cells,
gastrin stimulated Reg mRNA abundance; this was eliminated by the
gastrin/cholecystokinin B antagonist L-740,093 (10(-9) mol/L).
Immunocytochemistry indicated that Reg was located in both chief cells
and ECL cells in human corpus. Mutations of Reg were identified in 3 of
5 patients with ECL cell carcinoid tumors; in 2 cases, mutation of the
initiator methionine residue led to exclusion of the protein from the
secretory pathway. CONCLUSIONS: Gastrin regulates Reg mRNA abundance in
human corpus. Mutations of Reg that prevent secretion are associated
with ECL cell carcinoids, suggesting a function as an autocrine or
paracrine tumor suppressor.
3
UI - 11956615
AU - Onogawa S; Tanaka S; Oka S; Morihara M; Kitadai Y; Sumii M; Yoshihara M;
TI -
Shimamoto F; Haruma K; Chayama K
Clinical significance of angiogenesis in rectal carcinoid tumors.
SO - Oncol Rep 2002 May-Jun;9(3):489-94
AD - Department of Endoscopy, Hiroshima University School of Medicine,
Hiroshima 734-8551, Japan.
This study was designed to examine angiogenesis in rectal carcinoid
tumors in relation to the clinicopathologic features. Seventy-seven
rectal carcinoid tumors were studied clinicopathologically and
experimentally. Cellular proliferation and microvessel density (MVD)
were examined immunohistochemically. We used the antibodies MIB-1 for
Ki-67, DO7 for p53, and NU-4A1 for CD34 expression in this study. Ki-67
labeling index (LI) of all lesions was below 3%, and the median Ki-67 LI
of all lesions was 0.68+/-0.70% (mean +/- SD). A correlation was
recognized between tumor size, metastasis and Ki-67 LI (p<0.05). Median
MVD of all lesions was 25.9+/-13.1 (mean +/- SD). MVD was correlated
with the tumor size (p<0.01), presence of depression (p<0.01), lymphatic
(p<0.01) or venous (p<0.05) invasion, and existence of metastasis
(p<0.01). But there was no significant relationship between MVD and
Ki-67 LI. p53 protein was detected sporadically in only 1 case (1.3%)
demonstrating both liver and lymph node metastases. Rectal carcinoid
tumors are slow-growing tumors with a lower proliferative activity.
Angiogenesis plays an important role in progression of rectal carcinoid
tumors independent of the cellular proliferative activity.
4
UI - 11579679
AU - Tomita T
TI -
Immunocytochemical localization of prohormone convertase 1/3 and 2 in
gastrointestinal carcinoids.
SO - Endocr Pathol 2001 Summer;12(2):137-45
AD - Department of Pathology and Laboratory Medicine, University of Kansas
Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160, USA.
Gastrointestinal carcinoids are derived from the diffuse intestinal
endocrine system and may produce amines and many peptides, including
serotonin, chromogranin A (CGA), and tachykinins. Most peptide hormones
are synthesized as bigger prohormones, which are processed to smaller
active hormones by prohormone convertases (PCs). A total of 35 cases of
gastrointestinal carcinoids, including gastric, duodenal, small
intestinal, appendiceal, and large intestinal carcinoids, were
immunocytochemically stained for serotonin, CGA, and PC 1/3 and 2, in
order to colocalize CGA and PCs in the carcinoids. All carcinoids were
positive for CGA and PCs. Carcinoids that stained strongly for CGA were
generally weakly stained for PCs and those weakly staining for CGA were
more strongly stained for PCs in the majority of the small and large
intestinal tumors. Gastrointestinal carcinoids were positive for CGA and
PCs, and the presence of PCs may suggest that the conversion of peptide
prohormones to smaller peptide hormones occurs in gastrointestinal
carcinoids. PCs immunocytochemistry may be added as a new phenotypic
characterization for gastrointestinal carcinoids.
5
UI - 12192202
AU - Rybalov S; Kotler DP
TI -
Gastric carcinoids in a patient with pernicious anemia and familial
adenomatous polyposis.
SO - J Clin Gastroenterol 2002 Sep;35(3):249-52
AD - Division of Gastroenterology, St. Luke's Roosevelt Hospital Center, New
York, New York, USA. srybalov@pol.net
Familial adenomatous polyposis (FAP) is associated with upper
gastrointestinal adenomas and adenocarcinomas. A carcinoid tumor in the
base of a duodenal adenoma in a patient with FAP was documented only
once before. We report a patient with FAP who has multiple gastric
carcinoids plus pernicious anemia as a coexisting disease. Genetic
analysis and studies of other FAP patients are necessary to establish
whether an association exists between FAP and carcinoid tumors. Optimal
management of this type of gastric carcinoid is uncertain.
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.